World-class universities, prominent medical institutions, a talented workforce, access to capital and favorable geography are critical factors required to stimulate and support a dynamic regional bioscience industry. Some might believe that these factors only converge along the coasts of New England and California, and many new and growing biotech companies may feel that they are … Continue reading “Houston Dares to Challenge the Bicoastal Model of Biotech Growth”
Author: Neil Warma
Neil K. Warma was appointed president and chief executive officer of Opexa Therapeutics in June 2008 and is a member of its board of directors. He has more than 20 years of executive-level experience in the life sciences industry in the U.S., Europe, and Canada. Prior to joining Opexa, Warma served as President & CEO and a member of the board of directors of Viron Therapeutics, a privately-held clinical stage biopharmaceutical company developing a novel class of protein therapeutics. While at Viron, Warma positioned the company as a leader in the treatment of serious inflammatory disorders.
Previously, he held several senior management positions at Novartis Pharmaceuticals at its corporate headquarters in Basel, Switzerland, in international policy and advocacy and in global marketing. In addition, Warma was co-founder and president of MedExact USA, an Internet company providing clinical information and services to physicians and pharmaceutical companies, which was ultimately sold to a large public European firm.